Femasys Inc. Announces Commercial Availability of its FemCath Intrauterine Device

Go back to Femasys Inc. Announces Commercial Availability of its FemCath Intrauterine Device
(NASDAQ: FEMY) Delayed: 2.98 -0.08 (2.61%)
Previous Close $3.06    52 Week High
Open $3.03    52 Week Low
Day High $3.06    P/E N/A 
Day Low $2.93    EPS
Volume 51,353